Menu
Science Library Abstract
Published: 2021
SYNOPSIS

We examined whether existing licensed pharmacotherapies could reduce the spread of coronavirus disease 2019 (COVID-19).

TITLE

Positive impact of oral hydroxychloroquine and povidone-iodine throat spray for COVID-19 prophylaxis: An open-label randomized trial

CITATION

Seet RCS, Quek AML, Ooi DSQ, et al.  Int J Infect Dis. 2021;106:314-322. doi:10.1016/j.ijid.2021.04.035 https://pubmed.ncbi.nlm.nih.gov/33864917/

SUMMARY

Chemoprophylaxis with either oral hydroxychloroquine or povidone-iodine throat spray was superior to oral vitamin C in reducing SARS-CoV-2 infection in young and healthy men.

View Abstract

TAGS